Jennifer Tseng

1.1k total citations
23 papers, 796 citations indexed

About

Jennifer Tseng is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jennifer Tseng has authored 23 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Jennifer Tseng's work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Jennifer Tseng is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Jennifer Tseng collaborates with scholars based in United States, Switzerland and Germany. Jennifer Tseng's co-authors include Roy S. Herbst, Michael N. Needle, Mansoor N. Saleh, Frank V. Fossella, Francisco Robert, George Blumenschein, Waun Ki Hong, James M. Pluda, Lee M. Ellis and James L. Abbruzzese and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Jennifer Tseng

22 papers receiving 773 citations

Peers

Jennifer Tseng

ONCOL

PRM

GENET

Mary A. Kosir United States

Brandi T. Nicholson United States

Theresa Guo United States

Andrew Menzin United States

S. David Nathanson United States

Barbara Selle Germany

Michael Kuettel United States

Daniel C. Moreira United States

Saskia Spaich Germany

Yasushi Matsuyama Japan

Mary A. Kosir United States

Jennifer Tseng

328 ×1.0

ONCOL

221 ×0.7

67 ×0.3

PRM

258 ×1.6

54 ×0.6

GENET

Citations per year, relative to Jennifer Tseng Jennifer Tseng (= 1×) peers Mary A. Kosir

Countries citing papers authored by Jennifer Tseng

Since Specialization

Citations

This map shows the geographic impact of Jennifer Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Tseng more than expected).

Fields of papers citing papers by Jennifer Tseng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Tseng. The network helps show where Jennifer Tseng may publish in the future.

Co-authorship network of co-authors of Jennifer Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Tseng. A scholar is included among the top collaborators of Jennifer Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Tseng. Jennifer Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Trivedi, Meghna S., Rebecca Shatsky, Rita Nanda, et al.. (2024). LBA15 Rates of pathologic complete response (pCR) after datopotamab deruxtecan (Dato) plus durvalumab (Durva) treatment strategy in the neoadjuvant setting: Results from the I-SPY 2.2 trial. Annals of Oncology. 35. S1208–S1209. 1 indexed citations

Tseng, Jennifer, et al.. (2021). Role of immunotherapy in oligometastatic nonsmall cell lung cancer. BMJ Case Reports. 14(5). e241070–e241070.

Jin, Linchun, Dunrui Wang, Kristianna M. Fredenburg, et al.. (2018). CD70 as a target for chimeric antigen receptor T cells in head and neck squamous cell carcinoma. Oral Oncology. 78. 145–150. 53 indexed citations

William, William N., Jennifer Tseng, Shanthi Marur, et al.. (2018). Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinoma. Oral Oncology. 82. 83–90. 17 indexed citations

Mañon, R., Veronica Schimp, Priya Gopalan, Kavita M. Pattani, & Jennifer Tseng. (2015). The Impact of HPV as an Etiological Factor in Gynecological and Oropharyngeal Cancer. American Journal of Lifestyle Medicine. 10(4). 253–261. 3 indexed citations

Tseng, Jennifer, Birat Dhungel, Jane K. Mills, et al.. (2014). Merkel cell carcinoma: what makes a difference?. The American Journal of Surgery. 209(2). 342–346. 8 indexed citations

Wang, Jennifer, Shi‐Ming Tu, Lance C. Pagliaro, et al.. (2014). A prospective randomized phase III trial comparing consolidation therapy with or without strontium-89 following induction chemotherapy in androgen-independent prostate cancer.. Journal of Clinical Oncology. 32(4_suppl). 90–90. 2 indexed citations

Tseng, Jennifer & Susan L. Orloff. (2014). Management of Symptomatic Polycystic Liver Disease With Hepatic Resection. JAMA Surgery. 150(1). 81–81. 11 indexed citations

Pawel, Joachim von, Jennifer Tseng, Mircea Dediu, et al.. (2014). Phase 2 HERALD study of patritumab (P) with erlotinib (E) in advanced NSCLC subjects (SBJs).. Journal of Clinical Oncology. 32(15_suppl). 8045–8045. 19 indexed citations

10.

Schenning, Katie J. & Jennifer Tseng. (2013). Toward a Humanistic Learning Environment: Addressing Resident Mistreatment. Journal of Graduate Medical Education. 5(2). 344–344. 2 indexed citations

11.

Glisson, Bonnie S., Jennifer Tseng, Shanthi Marur, et al.. (2013). Randomized phase II trial of cixutumumab (CIX) alone or with cetuximab (CET) for refractory recurrent/metastatic squamous cancer of head and neck (R/M-SCCHN).. Journal of Clinical Oncology. 31(15_suppl). 6030–6030. 7 indexed citations

12.

Brown, Clarence H., Said Baidas, Julio Hajdenberg, et al.. (2009). Lifestyle Interventions in the Prevention and Treatment of Cancer. American Journal of Lifestyle Medicine. 3(5). 337–348. 7 indexed citations

13.

Tseng, Jennifer. (2008). Sex, Gender, and Why the Differences Matter. The AMA Journal of Ethic. 10(7). 427–428. 16 indexed citations

14.

Lilenbaum, Rogério, Luis E. Raez, Jennifer Tseng, L. Seigel, & Enrique Davila. (2008). Efficacy and Safety of Oxaliplatin and Gemcitabine with Bevacizumab in Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 3(5). 511–515. 22 indexed citations

15.

Robert, Francisco, George Blumenschein, Roy S. Herbst, et al.. (2005). Phase I/IIa Study of Cetuximab With Gemcitabine Plus Carboplatin in Patients With Chemotherapy-Naïve Advanced Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 23(36). 9089–9096. 130 indexed citations

16.

Herbst, Roy S., Kenneth R. Hess, Hai T. Tran, et al.. (2002). Phase I Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 20(18). 3792–3803. 216 indexed citations

17.

Tseng, Jennifer, Bonnie S. Glisson, Fadlo R. Khuri, et al.. (2001). Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck. Cancer. 92(9). 2364–2373. 40 indexed citations

18.

Tseng, Jennifer, B L Kemp, Fadlo R. Khuri, et al.. (1999). Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.. PubMed. 59(19). 4798–803. 80 indexed citations

19.

Tseng, Jennifer, Marivonne Rodriguez, Jae Y. Ro, et al.. (1999). Gender differences in p53 mutational status in small cell lung cancer.. PubMed. 59(22). 5666–70. 20 indexed citations

20.

Tseng, Jennifer, Sharon Hall, Thad A. Howard, & Russell E. Ware. (1995). Phenotypic and functional analysis of lymphocytes in paroxysmal nocturnal hemoglobinuria. American Journal of Hematology. 50(4). 244–253. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact